SCHEMBL23233597

SCHEMBL23233597

c1cc(-c2ccc(N(c3ccc4oc5ccccc5c4c3)c3ccccc3-c3ccc4c(c3)oc3ccccc34)cc2)cc(-c2ccc3ccccc3c2)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HCRTR1 O43613 1/20 0.35
▸ PLA2G2A P14555 3/20 0.34
▸ PLA2G4A P47712 3/20 0.34
▸ ALOX5 P09917 1/20 0.33
▸ ANO1 Q5XXA6 1/20 0.32
▸ MMP12 P39900 1/20 0.32
▸ MMP13 P45452 1/20 0.32
▸ PLA2G10 O15496 1/20 0.32
▸ PRKDC P78527 2/20 0.32
▸ PGR P06401 1/20 0.32
▸ AHR P35869 2/20 0.32
▸ KDM4E B2RXH2 2/20 0.32
▸ MEN1 O00255 2/20 0.32
▸ ALDH1A1 P00352 2/20 0.32
▸ MAPT P10636 2/20 0.32
▸ HPGD P15428 2/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ NPC1 O15118 2/20 0.32
▸ RAB9A P51151 2/20 0.32
▸ HSD17B1 P14061 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23232749 0.97 HCRTR1 (0.35) HCRTR1PLA2G2APLA2G4AALOX5ANO1
SCHEMBL24964657 0.97 HCRTR1 (0.35) HCRTR1PLA2G2APLA2G4AALOX5ANO1
SCHEMBL23231639 0.97 HCRTR1 (0.37) HCRTR1ALOX5MMP12MMP13PRKDC
SCHEMBL23231640 0.97 HCRTR1 (0.37) HCRTR1ALOX5MMP12MMP13PRKDC
SCHEMBL23232750 0.96 PLA2G2A (0.34) HCRTR1PLA2G2APLA2G4AALOX5ANO1
SCHEMBL24841861 0.96 PLA2G2A (0.36) PLA2G2APLA2G4AALOX5ANO1PLA2G10
SCHEMBL23233681 0.96 HCRTR1 (0.36) HCRTR1PLA2G2APLA2G4AALOX5ANO1
SCHEMBL24841377 0.96 PLA2G2A (0.36) PLA2G2APLA2G4AALOX5ANO1PLA2G10
SCHEMBL23233163 0.96 PLA2G2A (0.36) PLA2G2APLA2G4AALOX5ANO1PLA2G10
SCHEMBL23233099 0.96 HCRTR1 (0.37) HCRTR1PLA2G2APLA2G4AALOX5ANO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230026162-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-01-26 — — US disclosed
WO-2021070963-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE 出光興産株式会社 2021-04-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230026162-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE L1CAM, LEF1, MLX HCRTR1 3134/4885PLA2G2A 3282/4885PLA2G4A 3577/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback